What Recurrent Chemical Pregnancies May Reveal About Progesterone

A chemical pregnancy is a pregnancy. It is also a loss.

It happens early, before an ultrasound can confirm a heartbeat, sometimes before a missed period. A home test turns positive. And then, within days, it doesn't stay positive. Bleeding arrives. The number that was rising starts to fall.

For many women, a single chemical pregnancy comes with the reassurance that it's common, that it reflects a chromosomally abnormal embryo, that it's the body doing what it's supposed to do, that it has no bearing on future pregnancies.

That reassurance is often true. For a first chemical pregnancy, it may be all there is to say.

But when it happens again. And again. The answer "it's just bad luck" starts to feel less like comfort and more like a door closing on an explanation that might actually exist.

This article is for women who are in that second or third place. Who conceived, and then didn't stay pregnant, more than once. Who want to understand what clinicians look for, and where hormone patterns, specifically progesterone, may provide meaningful clues.

Recurrent chemical pregnancies occupy a uniquely difficult space.

You were pregnant. You lost the pregnancy. And because it happened early, many women feel pressure to move on before they've had time to process what happened.

The grief is real. The questions are too.

What actually happens during a chemical pregnancy?

A chemical pregnancy occurs when an egg is fertilized and implants, or begins to implant, but the pregnancy doesn't develop enough to be detected on ultrasound. hCG rises enough to trigger a positive pregnancy test. But something in the process of early pregnancy establishment fails, and the pregnancy ends before the fifth or sixth week.

The word "chemical" refers to the biochemical detection, the hCG that appeared on the test. It doesn't diminish what happened. It's a pregnancy that began and didn't continue.

Most chemical pregnancies are caused by chromosomal abnormalities in the embryo. The embryo itself carried an error that made development impossible, and the pregnancy ended as a result. This is true across all types of early pregnancy loss, and it's why a single chemical pregnancy is rarely investigated further.¹

But chromosomal abnormality is a random event. It's not systematically more likely to happen to the same woman three times in a row. When chemical pregnancies recur, clinicians begin looking for something else, something in the environment the embryo is being asked to develop in, rather than in the embryo itself.

That environment is largely hormonal.

Why does recurrence change the picture?

One chemical pregnancy: likely chromosomal. Two or three: the conversation shifts.

Recurrent pregnancy loss is typically defined as two or more pregnancy losses, and it prompts investigation into factors that might systematically compromise the early pregnancy environment. These include uterine structural issues, clotting disorders, immune factors, chromosomal factors in the parents, and hormonal patterns, including progesterone.²

Progesterone is not the only thing clinicians investigate. It is one of several. But it is one of the most directly relevant to what happens in the days immediately after fertilization, and it is also one of the most commonly underdiagnosed contributors to recurrent early loss, because standard testing doesn't always capture it.

The question worth asking isn't "is progesterone the cause?" It's: "could a progesterone pattern be part of what's happening, and is it worth finding out?"

The question worth asking isn't "is progesterone the cause?" It's: "could a progesterone pattern be part of what's happening, and is it worth finding out?"

What does progesterone actually do in early pregnancy?

After ovulation, the corpus luteum, the structure left behind in the follicle after the egg is released, begins producing progesterone. That progesterone has a specific and critical job: preparing the uterine lining for implantation and sustaining the early pregnancy until the placenta is developed enough to take over.³

This process is called luteal support. And it requires not just adequate progesterone levels, but adequate progesterone across the right window of time.

Progesterone does several things in early pregnancy that matter:

It transforms the uterine lining into a receptive environment for the embryo to implant. It suppresses uterine contractions that could dislodge an implanting embryo. It supports the immune environment of the uterus, modulating the maternal immune response so the embryo, which is genetically foreign, isn't rejected. It maintains the endometrium in the early weeks before the placenta can produce its own hormonal support.⁴

When progesterone is adequate and sustained across this window, the embryo has the conditions it needs. When it's not, when levels are too low, when they rise too slowly, or when they drop before the placenta is ready to take over, implantation may fail or the pregnancy may end before the seventh or eighth week.

Why might progesterone be insufficient in some women?

The most common scenario isn't that a woman simply has "low progesterone" as a fixed trait. It's that her progesterone pattern, how it rises after ovulation, how long it's sustained, how high it gets in the luteal phase, may not consistently reach the threshold needed to support early implantation.

Several things can affect this:

Luteal phase quality. The corpus luteum that produces progesterone after ovulation is only as robust as the follicle it came from. A follicle that didn't mature fully may produce a weaker corpus luteum and lower, shorter progesterone output. This is sometimes called luteal phase defect, a pattern where progesterone is insufficient relative to what's needed for implantation, even when a cycle appeared normal.⁵

A short luteal phase. If the luteal phase is shorter than approximately 10 to 11 days, the window for implantation may be compressed. The embryo may not have enough time to implant and signal adequately before progesterone begins to drop and the uterine lining begins to shed.

Anovulatory or poor-quality ovulation. Without a true ovulatory event, progesterone production is minimal. A cycle can look regular from the outside, with a period arriving on schedule, and still have produced insufficient progesterone. Some women have what appears to be an LH surge without a true egg release, resulting in inadequate corpus luteum function.⁶

Subclinical hypothyroidism or elevated prolactin. Both can interfere with progesterone production and the hormonal environment of early pregnancy. These are typically tested as part of a recurrent loss workup.

Age-related follicle quality changes. As women move through their mid-to-late 30s, follicle quality and corpus luteum function can decline. This may not show up on standard fertility panels but may manifest as progesterone patterns that are increasingly marginal.

The important thing to understand is that progesterone insufficiency in this context is often a pattern problem, not a level problem. A single progesterone blood draw, even a normal-looking one, may not capture whether levels were adequate across the implantation window, or whether they declined too early.

Consider two women with identical day-21 progesterone results. Both show ovulation occurred. Both numbers fall within the reference range.

One woman sustains progesterone across the full implantation window, days 6 through 10 past ovulation, giving an embryo adequate time and hormonal support to establish. The other sees her progesterone begin to decline by day 7 or 8 past ovulation, before implantation is complete.

The difference isn't the number. It's the pattern across time.

That distinction is what a single blood draw cannot show, and it's precisely why some women cycle through normal-looking results while continuing to experience early loss.

Why doesn't standard testing catch this?

This is the question that frustrates many women who have been through recurrent loss and received inconclusive workups.

Standard progesterone testing in fertility medicine typically involves a single blood draw around day 21 of a 28-day cycle, designed to confirm that ovulation occurred, not to assess the quality or duration of luteal phase support.⁷

That single number may look fine. It may even be in the range typically considered adequate. But it doesn't tell you:

Whether progesterone rose quickly enough in the days immediately after ovulation, when the uterine lining first needs to transform.

Whether it stayed elevated through the implantation window, typically days 6 through 10 past ovulation.

Whether it began declining before the placenta was ready to take over.

Whether the pattern varies cycle to cycle, with some cycles producing adequate luteal support and others not.

A woman can have a day-21 progesterone of 12 ng/mL, technically in the post-ovulatory range, and still have a luteal phase that doesn't sustain implantation adequately. The snapshot shows ovulation occurred. It doesn't show whether the luteal phase that followed was sufficient.

For more on how low progesterone symptoms present and differ from other hormonal patterns, the comparison can help clarify what to watch for.

What do clinicians typically investigate after recurrent chemical pregnancies?

A standard recurrent pregnancy loss workup typically includes:

Uterine evaluation. Structural abnormalities, including a septum, fibroids, or polyps, can interfere with implantation. A hysteroscopy or saline sonogram is usually part of the initial workup.

Clotting and immune factors. Antiphospholipid syndrome is one of the most clearly evidence-based causes of recurrent pregnancy loss. It causes clotting in the small vessels that supply the early placenta. Testing for antiphospholipid antibodies is standard.

Chromosomal testing of both partners. Balanced chromosomal translocations, rearrangements that don't affect the carrier but produce abnormal embryos, account for a portion of recurrent losses.

Thyroid function and prolactin. Both affect the hormonal environment of early pregnancy and are treatable when abnormal.

Progesterone and luteal phase assessment. This is where the evaluation is least standardized and most likely to miss the relevant pattern. Some clinicians order a single day-21 draw. Others may recommend more frequent progesterone monitoring across the luteal phase, or empirical progesterone supplementation even without confirmed deficiency.⁸

The honest answer is that for many women with recurrent chemical pregnancies, a standard workup returns without a clear finding. This doesn't mean nothing is wrong. It may mean the available testing didn't capture the right dimension of what's happening, particularly around the timing and pattern of luteal phase support.

What role can hormone pattern data play?

This is where longitudinal monitoring, tracking progesterone across the luteal phase rather than at a single point, becomes meaningful.

A pattern of how progesterone rises, peaks, and sustains in the days after ovulation can reveal things a single blood draw cannot:

Whether ovulation was confirmed with certainty, including the exact day, which affects the accuracy of any subsequent progesterone timing.

Whether the luteal phase is consistently short or variable.

Whether progesterone rises adequately in the early luteal phase, when implantation is being established.

Whether the pattern is consistent cycle to cycle, or whether some cycles produce stronger luteal support than others.

This is the kind of data that allows a more nuanced conversation with a reproductive endocrinologist, not just "my progesterone was 12 on day 21," but "here is what my progesterone pattern looked like across three cycles, and here is where it appears to fall short."

For context on what a normal progesterone pattern looks like across the luteal phase, and what patterns may provide clues about fertility, understanding what progesterone levels mean for fertility is a useful starting point.

Is progesterone supplementation effective for recurrent chemical pregnancy?

The evidence here is nuanced, and it's worth being honest about that.

Progesterone supplementation (typically vaginal progesterone suppositories or oral micronized progesterone) is widely used as empirical treatment for recurrent pregnancy loss, including in women without confirmed progesterone deficiency.

Several studies, including the PROMISE and PRISM trials conducted in the UK, have examined whether progesterone supplementation reduces pregnancy loss in women with unexplained recurrent loss. Results have been mixed, with some suggestion of benefit in women with prior loss and threatened miscarriage, and less clear benefit in unselected populations.⁹

What the evidence does suggest:

In women with confirmed low progesterone, supplementation during the luteal phase and early pregnancy is standard practice and well-supported.

In women with unexplained recurrent loss, empirical supplementation is commonly offered even without confirmed deficiency, given a favorable safety profile and the possibility of benefit.

The question of whether to supplement is best made with a reproductive endocrinologist who can weigh individual history, prior workup findings, and the specific clinical picture.

What's consistent across studies is that progesterone supplementation appears safer than it is harmful, which is why many clinicians offer it even in the absence of definitive evidence of deficiency.

What this doesn't mean

Progesterone is not the answer to all recurrent chemical pregnancies. For many women, the cause remains unclear even after a thorough workup. For others, the cause is chromosomal, an answer that progesterone supplementation cannot change.

This article is not a diagnosis. It is an invitation to ask a different question.

If you have experienced two or more chemical pregnancies, you deserve an investigation that goes beyond reassurance. Not because something is necessarily wrong, but because there may be something measurable, a luteal phase pattern, a hormonal trend, a clinical finding, that changes the picture.

The uncertainty that follows recurrent loss is one of the hardest places to be. You are trying to understand something that medicine itself doesn't always have clean answers for. That uncertainty is real. And so is the possibility that more information, about your specific hormonal pattern, your specific cycle, your specific luteal phase, could move you closer to an answer.

Recurrent chemical pregnancies are not always preventable. They are not always caused by progesterone.

But they are a reason to ask deeper questions.

And when a pattern exists, finding it is often the first step toward understanding what comes next.

Frequently Asked Questions

Is a chemical pregnancy the same as a miscarriage? 

Clinically, a chemical pregnancy is a very early pregnancy loss, one that occurs before the pregnancy is visible on ultrasound, typically before 5 to 6 weeks. Whether it is called a miscarriage depends on clinical context, but it represents a real pregnancy that began and didn't continue.

When do recurrent chemical pregnancies warrant investigation? 

Most guidelines recommend investigation after two or more pregnancy losses. Some clinicians begin evaluating after two losses in women over 35, or when there is other reason for concern. A reproductive endocrinologist is the appropriate specialist to guide this evaluation.

Does low progesterone always cause chemical pregnancy? 

No. Low progesterone is one of several possible contributors. Many chemical pregnancies are caused by chromosomal abnormalities in the embryo. When losses recur, progesterone becomes a more relevant area of investigation, but it is one factor among several.

How is luteal phase defect diagnosed?

There is no universally agreed-upon diagnostic standard. A single day-21 progesterone draw is commonly used to confirm ovulation but may not adequately assess luteal phase quality. Endometrial biopsy has historically been used but is no longer standard. Serial progesterone measurements across the luteal phase, or monitoring of ovulation and luteal phase length over multiple cycles, may provide more complete information.

Can I take progesterone without a diagnosis? 

Empirical progesterone supplementation is commonly offered in cases of unexplained recurrent pregnancy loss, even without confirmed deficiency, because of its favorable safety profile and potential benefit. This is a decision best made with a reproductive endocrinologist based on your full clinical picture.

What should I ask my doctor after two chemical pregnancies? 

Ask for a formal recurrent pregnancy loss workup. This should include uterine evaluation, antiphospholipid antibody testing, thyroid function, prolactin, and chromosomal testing of both partners. Ask specifically whether luteal phase progesterone monitoring, not just a single day-21 draw, has been considered.